Atlas Trials

Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease

Clinical trial NCT07363265 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07363265
Sponsor
Longbio Pharma
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Complement-mediated Renal Diseases
Start date
2026-02-02
Primary completion
2028-08-02
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.